Sfoglia per Autore
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
2022 Kulp, M; Siemund, A; Larghero, P; Dietz, A; Alten, J; Cario, G; Eckert, C; Caye-Eude, A; Cave, H; Bardini, M; Cazzaniga, G; De Lorenzo, P; Valsecchi, M; Diehl, L; Bonig, H; Meyer, C; Marschalek, R
Identical EP300 variant leading to Rubinstein–Taybi syndrome with different clinical and immunologic phenotype
2022 Saettini, F; Fazio, G; Bonati, M; Moratto, D; Massa, V; Di Fede, E; Castiglioni, S; Marchetti, D; Chiarini, M; Sottini, A; Iascone, M; Cazzaniga, G; Imberti, L; Biondi, A; Gervasini, C; Badolato, R
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
2022 Fazio, G; Bresolin, S; Silvestri, D; Quadri, M; Saitta, C; Vendramini, E; Buldini, B; Palmi, C; Bardini, M; Grioni, A; Rigamonti, S; Galbiati, M; Mecca, S; Savino, A; Peloso, A; Tu, J; Bhatia, S; Borkhardt, A; Micalizzi, C; Lo Nigro, L; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Te Kronnie, G; Biondi, A; Cazzaniga, G
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol
2022 Stutterheim, J; de Lorenzo, P; van der Sluin, I; Alten, J; Ancliffe, P; Attarbaschi, A; Aversa, L; Boer, J; Biondi, A; Brethon, B; Diaz, P; Cazzaniga, G; Escherich, G; Ferster, A; Kotecha, R; Lausen, B; Leung, A; Locatelli, F; Silverman, L; Stary, J; Szczepanski, T; van der Velden, V; Vora, A; Zuna, J; Schrappe, M; Valsecchi, M; Pieters, R
Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia
2022 Severgnini, M; D'Angiò, M; Bungaro, S; Cazzaniga, G; Cifola, I; Fazio, G
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome
2022 Saettini, F; Coliva, T; Vendemini, F; Galbiati, M; Bugarin, C; Masetti, R; Moratto, D; Chiarini, M; Guerra, F; Iascone, M; Badolato, R; Cazzaniga, G; Niemeyer, C; Flotho, C; Biondi, A
Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia
2021 Ceppi, F; Rizzati, F; Colombini, A; Conter, V; Cazzaniga, G
HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia
2021 de Barrios, O; Galaras, A; Trincado, J; Azagra, A; Collazo, O; Meler, A; Agraz-Doblas, A; Bueno, C; Ballerini, P; Cazzaniga, G; Stam, R; Varela, I; De Lorenzo, P; Valsecchi, M; Hatzis, P; Menendez, P; Parra, M
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants
2021 Fazio, G; Bardini, M; De Lorenzo, P; Grioni, A; Quadri, M; Pedace, L; Corral Abascal, L; Palamini, S; Palmi, C; Buldini, B; Vinti, L; Parasole, R; Barisone, E; Zecca, M; Favre, C; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Biondi, A; Cazzaniga, G
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
2021 Turati, V; Guerra-Assuncao, J; Potter, N; Gupta, R; Ecker, S; Daneviciute, A; Tarabichi, M; Webster, A; Ding, C; May, G; James, C; Brown, J; Conde, L; Russell, L; Ancliff, P; Inglott, S; Cazzaniga, G; Biondi, A; Hall, G; Lynch, M; Hubank, M; Macaulay, I; Beck, S; Van Loo, P; Jacobsen, S; Greaves, M; Herrero, J; Enver, T
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development
2021 Cazzola, A; Cazzaniga, G; Biondi, A; Meneveri, R; Brunelli, S; Azzoni, E
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
2021 Boer, J; Valsecchi, M; Hormann, F; Antic, Z; Zaliova, M; Schwab, C; Cazzaniga, G; Arfeuille, C; Cave, H; Attarbaschi, A; Strehl, S; Escherich, G; Imamura, T; Ohki, K; Gruber, T; Sutton, R; Pastorczak, A; Lammens, T; Lambert, F; Li, C; Carrillo de Santa Pau, E; Hoffmann, S; Moricke, A; Harrison, C; Den Boer, M; De Lorenzo, P; Stam, R; Bergmann, A; Pieters, R
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2
2021 Saettini, F; Castelli, I; Provenzi, M; Fazio, G; Quadri, M; Cazzaniga, G; Sala, S; Dell'Acqua, F; Sieni, E; Coniglio, M; Pezzoli, L; Iascone, M; Vendemini, F; Balduzzi, A; Biondi, A; Rizzari, C; Bonanomi, S
Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study
2021 van der Velden, V; Bruggemann, M; Cazzaniga, G; Scheijen, B; Tops, B; Trka, J; Pal, K; Hanzelmann, S; Fazio, G; Songia, S; Langerak, A; Darzentas, N; van der Velden, V
SSBP2-CSF1R is a Recurrent Fusion in B-lineage Acute Lymphoblastic Leukaemia with Diverse Genetic Presentation and Variable Outcome
2021 Schwab, C; Roberts, K; Boer, J; Gohring, G; Steinemann, D; Vora, A; Macartney, C; Hough, R; Thorn, Z; Dillon, R; Escherich, G; Cazzaniga, G; Schlegelberger, B; Loh, M; Den Boer, M; Moorman, A; Harrison, C
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
2021 Hirabayashi, S; Butler, E; Ohki, K; Kiyokawa, N; Bergmann, A; Moricke, A; Boer, J; Cave, H; Cazzaniga, G; Yeoh, A; Sanada, M; Imamura, T; Inaba, H; Mullighan, C; Loh, M; Noren-Nystrom, U; Pastorczak, A; Shih, L; Zaliova, M; Pui, C; Haas, O; Harrison, C; Moorman, A; Manabe, A
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
2021 Quintarelli, C; Guercio, M; Manni, S; Boffa, I; Sinibaldi, M; DI Cecca, S; Caruso, S; Abbaszadeh, Z; Camera, A; Cembrola, B; Ciccone, R; Orfao, A; Martin-Martin, L; Gutierrez-Herrero, S; Herrero-Garcia, M; Cazzaniga, G; Nunes, V; Songia, S; Marcatili, P; Marin, F; Ruella, M; Bertaina, V; Vinti, L; Del Bufalo, F; Algeri, M; Merli, P; De Angelis, B; Locatelli, F
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
2021 den Boer, M; Cario, G; Moorman, A; Boer, J; de Groot-Kruseman, H; Fiocco, M; Escherich, G; Imamura, T; Yeoh, A; Sutton, R; Dalla-Pozza, L; Kiyokawa, N; Schrappe, M; Roberts, K; Mullighan, C; Hunger, S; Vora, A; Attarbaschi, A; Zaliova, M; Elitzur, S; Cazzaniga, G; Biondi, A; Loh, M; Pieters, R
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency
2021 Saettini, F; Poli, C; Vengoechea, J; Bonanomi, S; Orellana, J; Fazio, G; Rodriguez III, F; Noguera, L; Booth, C; Jarur-Chamy, V; Shams, M; Iascone, M; Vukic, M; Gasperini, S; Quadri, M; Seijas, A; Rivers, E; Mauri, M; Badolato, R; Cazzaniga, G; Bugarin, C; Gaipa, G; Kroes, W; Moratto, D; van Oostaijen-Ten Dam, M; Baas, F; van der Maarel, S; Piazza, R; Coban-Akdemir, Z; Lupski, J; Yuan, B; Chinn, I; Daxinger, L; Biondi, A
Genetic and epigenetic characterization of a discordant kmt2a/aff1-rearranged infant monozygotic twin pair
2021 Russo, A; Viberti, C; Mareschi, K; Casalone, E; Guarrera, S; Birolo, G; Cazzaniga, G; Corral, L; Trentin, L; Basso, G; Fagioli, F; Matullo, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile